EMA Makes "Steady Progress" On Revising Pharmacovigilance Guideline For Pediatric Drugs
Executive Summary
The European Medicines Agency is revising its guideline on pharmacovigilance requirements for pediatric drugs to show how drug development plans can benefit from the new pharmacovigilance environment in both scientific and regulatory terms.
You may also be interested in...
Industry Underwhelmed By EMA Pediatrics Pharmacovigilance Guide Update Plans
By the time it is released early this year, it will have taken nearly three years for the European Medicines Agency's guideline on pharmacovigilance requirements for paediatrics to be updated. The agency’s proposals have failed to impress the pharmaceutical industry, which says among other things they contain little new information.
EU Consults On What Constitutes Personal & Commercially Confidential Data In Marketing Applications
Based on their experience with dealing with requests for access to documents over the past 12 years, EU regulators have proposed updating their guideline that provides for a harmonized approach to protecting personal data and business secrets in marketing authorization applications.
Global Pharma Guidance Tracker – March 2024
Stay up to date on regulatory guidelines from around the world with the Pink Sheet's Guidance Tracker. The complete Global Pharma Guidance Tracker, with sortable and searchable listings going back to 2014, is available online.